Literature DB >> 14962521

Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection.

C Herzog1, N Salès, N Etchegaray, A Charbonnier, S Freire, D Dormont, J-P Deslys, C I Lasmézas.   

Abstract

BACKGROUND: The disease-associated form of prion protein (PrP(res)) has been noted in lymphoreticular tissues in patients with variant Creutzfeldt-Jakob disease (vCJD). Thus, the disease could be transmitted iatrogenically by surgery or use of blood products. We aimed to assess transmissibility of the bovine spongiform encephalopathy (BSE) agent to primates by the intravenous route and study its tissue distribution compared with infection by the oral route.
METHODS: Cynomolgus macaques were infected either intravenously or orally with brain homogenates from first-passage animals with BSE. They were clinically monitored for occurrence of neurological signs and killed humanely at the terminal stage of the disease. Brain, lymphoreticular tissues, digestive tract, and peripheral nerves were obtained and analysed by sandwich ELISA and immunohistochemistry for quantitative and qualitative assessment of their PrP(res) content.
FINDINGS: Incubation periods after intravenous transmission of BSE were much shorter than after oral infection. We noted that PrP(res) was present in lymphoreticular tissues such as spleen and tonsils and in the entire gut from the duodenum to the rectum. In the gut, PrP(res) was present in Peyer's patches and in the enteric nervous system and nerve fibres of intestinal mucosa. Furthermore, PrP(res) was found in locomotor peripheral nerves and the autonomic nervous system. Amount of PrP(res) ranged from 0.02% to more than 10% of that recorded in brain. Distribution of PrP(res) was similar in animals infected by the intravenous or oral route.
INTERPRETATION: Our findings suggest that the possible risk of vCJD linked to endoscopic procedures might be currently underestimated. Human iatrogenic vCJD cases infected intravenously raise the same public-health concerns as primary cases and need the same precautionary measures with respect to blood and tissue donations and surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962521     DOI: 10.1016/S0140-6736(04)15487-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

Review 1.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Terminal ileal biopsies should not be used to document extent of colonoscopic examination.

Authors:  M D Rutter; M G Bramble
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

3.  Variant Creutzfeldt-Jakob disease: update.

Authors:  M G Bramble; J Ironside
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 4.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

5.  Transfusion and risk of infection in Canada: Update 2005.

Authors:  Noni Macdonald
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

6.  Transfusion and risk of infection in Canada: Update 2005.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-03       Impact factor: 2.253

7.  Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.

Authors:  Joanna Pankiewicz; Frances Prelli; Man-Sun Sy; Richard J Kascsak; Regina B Kascsak; Daryl S Spinner; Richard I Carp; Harry C Meeker; Marcin Sadowski; Thomas Wisniewski
Journal:  Eur J Neurosci       Date:  2006-05       Impact factor: 3.386

8.  Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.

Authors:  Steve Simoneau; Achim Thomzig; Marie-Madeleine Ruchoux; Nicolas Vignier; Martin L Daus; Anna Poleggi; Pierre Lebon; Sophie Freire; Valerie Durand; Silvia Graziano; Roberta Galeno; Franco Cardone; Emmanuel Comoy; Maurizio Pocchiari; Michael Beekes; Jean-Philippe Deslys; Jean-Guy Fournier
Journal:  Virulence       Date:  2015-01-13       Impact factor: 5.882

9.  Detection of disease-associated prion protein in the optic nerve and the adrenal gland of cattle with bovine spongiform encephalopathy by using highly sensitive immunolabeling procedures.

Authors:  Hiroyuki Okada; Yoshifumi Iwamaru; Shigeo Fukuda; Takashi Yokoyama; Shirou Mohri
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

10.  Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

Authors:  Susanne Krasemann; Melanie Neumann; Markus Geissen; Walter Bodemer; Franz-Josef Kaup; Walter Schulz-Schaeffer; Nathalie Morel; Adriano Aguzzi; Markus Glatzel
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.